Arca Biopharma | ABIO - Trade Creditors


Arca Biopharma reported $6.67M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 2.86B 16.65B Jun/2026
Arca Biopharma USD 6.67M 2.5M Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Capricor Therapeutics 3.08M 848.23K Jun/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.53M 173K Mar/2026
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 20.51M 4.2M Jun/2026
Daiichi Sankyo JPY 539.05B 57.81B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Grifols EUR 987.75M 47.87M Dec/2025
Laboratory Of America USD 688.5M 7.2M Jun/2026
Myriad Genetics USD 30.4M 2.2M Jun/2026
Otsuka Holdings JPY 216.64B 20.6B Jun/2026
Pfizer USD 4.58B 75M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026